Allopurinol and Pathogenesis of Cirrhosis | MicrobiomeTrials← Back to trialsNCT07033533
Allopurinol and Pathogenesis of Cirrhosis
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2023-06-01Est. Completion: 2024-03-01
Enrollment target: 110 participants Locations- Tanta University, Tanta, Egypt
Other microbiome trials you might be interested in
Liver CirrhosesPortal Hypertension Related to CirrhosisSevere ObesityTIPS
Cirrhosis is a form of advanced liver disease that can lead to serious complications, especially when combined with seve…
Cleveland, United StatesEst. completion Feb 1, 2029
Portal Hypertension Related to CirrhosisVariceal BleedingCirrhoses, Liver
The goal of this observational study is to learn about the outcomes of patients presenting with acute variceal bleeding …
Cluj-Napoca, RomaniaCompleted May 20, 2026